TWi Biotechnology, Inc(TW:6610)
NT$17.55-0.25 (-3.04%)
TW:6610
TWi Biotechnology, Inc financials statements
NT$17.55
At close:-0.25 (-3.04%)
TWi Biotechnology, Inc (6610) Financial Statements
TWi Biotechnology, Inc Financial Overview
TWi Biotechnology, Inc's market cap is currently NT$3.92B. The company's EPS TTM is NT$-1.46; its P/E ratio is -12.05; TWi Biotechnology, Inc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 0.00 | NT$ 0.00 | NT$ 0.00 | NT$ 0.00 | NT$ 66.40M |
| Gross Profit | NT$ -35.32M | NT$ -9.70M | NT$ -9.74M | NT$ -10.35M | NT$ 65.48M |
| Operating Income | NT$ -357.02M | NT$ -178.49M | NT$ -169.56M | NT$ -90.18M | NT$ -15.30M |
| EBITDA | NT$ -321.70M | NT$ -154.94M | NT$ -160.86M | NT$ -65.78M | NT$ -4.11M |
| Net Income | NT$ -202.37M | NT$ -164.81M | NT$ -170.68M | NT$ -76.18M | NT$ -15.30M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 263.72M | NT$ 175.60M | NT$ 323.69M | NT$ 160.40M | NT$ 223.14M |
| Total Assets | NT$ 723.58M | NT$ 242.32M | NT$ 396.85M | NT$ 234.31M | NT$ 311.04M |
| Total Debt | NT$ 2.95M | NT$ 15.60M | NT$ 7.97M | NT$ 2.53M | NT$ 5.02M |
| Net Debt | NT$ -260.77M | NT$ -111.19M | NT$ -143.86M | NT$ -157.87M | NT$ -183.81M |
| Total Liabilities | NT$ 93.14M | NT$ 66.47M | NT$ 55.81M | NT$ 28.39M | NT$ 32.24M |
| Stockholders' Equity | NT$ 630.44M | NT$ 175.85M | NT$ 341.04M | NT$ 205.92M | NT$ 278.80M |
| Cash Flow | |||||
| Free Cash Flow | NT$ -287.40M | NT$ -155.72M | NT$ -134.22M | NT$ -60.24M | NT$ -64.69M |
| Operating Cash Flow | NT$ -286.99M | NT$ -155.41M | NT$ -134.22M | NT$ -60.24M | NT$ -34.46M |
| Investing Cash Flow | NT$ 42.90M | NT$ 122.75M | NT$ -171.85M | NT$ 34.30M | NT$ 161.64M |
| Financing Cash Flow | NT$ 167.34M | NT$ 7.63M | NT$ 297.50M | NT$ -2.50M | NT$ -2.46M |
Currency in TWD

